Thomas D. Madden

Acuitas Therapeutics (Canada)

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes”.

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

Journal of Controlled Release(2015)10.1016/j.jconrel.2015.08.007

N/A

1.0DataRank · unranked

1015 citations

Steven Tuyishime, Hiromi Muramatsu, Barbara L. Mui, Ying K. Tam, Thomas D. Madden +4 more

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

Molecular Therapy(2020)10.1016/j.ymthe.2020.04.018

N/A

0DataRank · unranked

310 citations

Jamile Ramos da Silva, Victoria Rosado, Carly M. Bliss, Matthew Pine, Barbara L. Mui +10 more

Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema

Nature Communications(2021)10.1038/s41467-021-23546-6

N/A

0DataRank · unranked

62 citations

Gábor Kovács, Éva Kemecsei, László Bálint, Kitti Szoták-Ajtay, Petra Aradi +12 more